Submission Details
| 510(k) Number | K053020 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 26, 2005 |
| Decision Date | December 30, 2005 |
| Days to Decision | 65 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K053020 is an FDA 510(k) clearance for the TNL-ULTRA ASSAY FOR THE ADVIA CENTAUR SYSTEM, a Immunoassay Method, Troponin Subunit (Class II — Special Controls, product code MMI), submitted by Bayer Healthcare, LLC (New York, US). The FDA issued a Cleared decision on December 30, 2005, 65 days after receiving the submission on October 26, 2005. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1215.
| 510(k) Number | K053020 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 26, 2005 |
| Decision Date | December 30, 2005 |
| Days to Decision | 65 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | MMI — Immunoassay Method, Troponin Subunit |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.1215 |